Literature DB >> 27893328

What's in a Name? Steady Progress in Staging Pancreatic Neuroendocrine Tumors.

Daniel M Halperin1, James C Yao1, Arvind Dasari1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27893328     DOI： 10.1200/JCO.2016.70.7364

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Costs of Cancer Care for Elderly Patients with Neuroendocrine Tumors.

Authors:  Chan Shen; Arvind Dasari; Dian Gu; Yiyi Chu; Shouhao Zhou; Ying Xu; Daniel Halperin; Shuangshuang Fu; James C Yao; Ya-Chen Tina Shih
Journal:  Pharmacoeconomics       Date:  2018-08       Impact factor: 4.981

2.  Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy.

Authors:  Fabrice Viol; Bence Sipos; Martina Fahl; Till S Clauditz; Tania Amin; Malte Kriegs; Maike Nieser; Jakob R Izbicki; Samuel Huber; Ansgar W Lohse; Jörg Schrader
Journal:  Cell Oncol (Dordr)       Date:  2022-10-21       Impact factor: 7.051

3.  Progress in TNM staging of pancreatic neuroendocrine tumors.

Authors:  Taymeyah Al-Toubah; Jonathan Strosberg
Journal:  Hepatobiliary Surg Nutr       Date:  2021-04       Impact factor: 7.293
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.